Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,294,543
+$11,488,363 QoQ
Shares Held
2,879,289
0.0% QoQ
Ownership
3.99%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#7
of 158 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. FDMT ranks #24 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,965,160 | $555,315,164 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
3,872,052 | $444,008,202 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
16,001,284 | $311,544,999 | |
| 4 | GHRS |
GH Research PLC
|
8,650,158 | $232,516,247 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
3,366,823 | $180,697,390 | |
| 6 | NKTR |
Nektar Therapeutics
|
2,391,075 | $166,920,945 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,056,027 | $123,629,080 | |
| 8 | XNCR |
Xencor Inc
|
7,133,720 | $114,852,892 |
All Filings in FDMT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,294,543 | 2,879,289 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $26,806,180 | 2,879,289 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $34,719,667 | 4,629,289 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $40,228,521 | 4,629,289 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,174,662 | 4,629,289 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,732,963 | 4,561,289 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,875,475 | 2,670,642 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $79,806,360 | 7,382,642 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $82,331,448 | 3,922,413 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $124,968,078 | 3,922,413 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $81,190,187 | 4,007,413 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $51,014,367 | 4,007,413 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $72,413,952 | 4,007,413 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $68,887,429 | 4,007,413 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $89,004,642 | 4,007,413 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $32,219,600 | 4,007,413 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,971,742 | 4,007,413 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $40,287,557 | 2,664,521 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $44,008,612 | 2,005,862 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $54,098,098 | 2,005,862 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $48,301,156 | 2,005,862 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $44,727,816 | 1,031,070 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $45,846,601 | 1,106,070 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||